Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Cardiol. Jun 26, 2025; 17(6): 106717
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.106717
Table 1 Baseline characteristics of the included patients
Variable
Transient improvement (n = 39)
Sustained improvement (n = 136)
P value
Age (years), mean ± SD58.15 ± 11.6954.51 ± 13.520.13
BMI (kg/m2), mean ± SD28.36 ± 5.6730.49 ± 7.200.09
Male37 (94.9)101 (74.3)0.005
Female2 (5.1)35 (25.7)-
HF etiology
Ischemic32 (82.1)68 (50.4)0.002
Dilated5 (12.8)57 (42.2)
Others2 (5.1)10 (7.4)
Duration of HF diagnosis, mean ± SD7.05 ± 3.815.79 ± 4.00.08
Comorbidities
Dyslipidemia24 (61.5)54 (39.7)0.03
Hypertension34 (87.2)93 (68.4)0.03
Diabetes28 (71.8)90 (66.2)0.57
Atrial fibrillation8 (20.5)25 (18.4)0.82
Ventricular arrhythmia5 (12.8)18 (13.2)1.00
CVA/TIA5 (12.8)16 (11.8)0.79
PAD2 (5.1)8 (5.9)1.00
Renal impairment17 (43.6)35 (25.7)0.05
Liver disease2 (5.1)5 (3.7)0.65
Anemia10 (25.6)38 (27.9)0.84
Sleep apnea0 (0)9 (6.6)0.21
Chronic lung disease6 (15.4)21 (15.4)1.00
Cancer0 (0)7 (5.1)0.35
Dementia2 (5.1)3 (2.2)0.31
Depression0 (0)6 (4.4)0.34
Hypothyroidism2 (5.1)11 (8.1)0.74
Hyperthyroidism0 (0)4 (2.9)0.58